MMP9 and neoplasm: On the contrary, NK cells representing a CD56brightCD16+ subset can facilitate tumor development by releasing the matrix metalloproteinase 9 (MMP9) and secreting the vascular endothelial growth factor (VEGF) and angiogenin [24,25].